News | April 10, 2023
Thermo Fisher Scientific expands its capabilities in France
Bourgoin early development hub broadens offerings for oral solid dose formulations
Bourgoin early development hub broadens offerings for oral solid dose formulations
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
The company is addressing these observations
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
The observations are procedural in nature
The company will be submitting the responses to US FDA observations within stipulated timeline
The inspection concluded with no observations
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP)
Subscribe To Our Newsletter & Stay Updated
